Pelizzaro, F.; Cardin, R.; Sartori, A.; Imondi, A.; Penzo, B.; Aliberti, C.; Ponzoni, A.; Vitale, A.; Cillo, U.; Farinati, F.
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines 2021, 9, 890.
https://doi.org/10.3390/biomedicines9080890
AMA Style
Pelizzaro F, Cardin R, Sartori A, Imondi A, Penzo B, Aliberti C, Ponzoni A, Vitale A, Cillo U, Farinati F.
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines. 2021; 9(8):890.
https://doi.org/10.3390/biomedicines9080890
Chicago/Turabian Style
Pelizzaro, Filippo, Romilda Cardin, Anna Sartori, Angela Imondi, Barbara Penzo, Camillo Aliberti, Alberto Ponzoni, Alessandro Vitale, Umberto Cillo, and Fabio Farinati.
2021. "Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization" Biomedicines 9, no. 8: 890.
https://doi.org/10.3390/biomedicines9080890
APA Style
Pelizzaro, F., Cardin, R., Sartori, A., Imondi, A., Penzo, B., Aliberti, C., Ponzoni, A., Vitale, A., Cillo, U., & Farinati, F.
(2021). Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization. Biomedicines, 9(8), 890.
https://doi.org/10.3390/biomedicines9080890